A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report†
出版年份 2014 全文链接
标题
A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report†
作者
关键词
-
出版物
NEURO-ONCOLOGY
Volume 16, Issue 12, Pages 1661-1668
出版商
Oxford University Press (OUP)
发表日期
2014-06-08
DOI
10.1093/neuonc/nou103
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A phase II study of the PARP inhibitor ABT-888 plus temozolomide in patients with heavily pretreated, metastatic colorectal cancer.
- (2017) M. J. Pishvaian et al. JOURNAL OF CLINICAL ONCOLOGY
- PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation
- (2015) Dannis Gilbert Van Vuurden et al. Oncotarget
- A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas
- (2012) S. Kummar et al. CLINICAL CANCER RESEARCH
- Synthetic Lethal Interactions between EGFR and PARP Inhibition in Human Triple Negative Breast Cancer Cells
- (2012) Somaira Nowsheen et al. PLoS One
- Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors
- (2011) P. Neri et al. BLOOD
- Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and Lymphomas
- (2011) S. Kummar et al. CANCER RESEARCH
- Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
- (2011) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- Response of Human Prostate Cancer Cells and Tumors to Combining PARP Inhibition with Ionizing Radiation
- (2011) J. C. Barreto-Andrade et al. MOLECULAR CANCER THERAPEUTICS
- Pediatric high-grade glioma: identification of poly(ADP-ribose) polymerase as a potential therapeutic target
- (2011) S. J. Smith et al. NEURO-ONCOLOGY
- Modeling Pharmacodynamic Response to the Poly(ADP-Ribose) Polymerase Inhibitor ABT-888 in Human Peripheral Blood Mononuclear Cells
- (2011) Jiuping Ji et al. PLoS One
- The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy
- (2011) Somaira Nowsheen et al. RADIOTHERAPY AND ONCOLOGY
- PTEN Loss Compromises Homologous Recombination Repair in Astrocytes: Implications for Glioblastoma Therapy with Temozolomide or Poly(ADP-Ribose) Polymerase Inhibitors
- (2010) B. McEllin et al. CANCER RESEARCH
- Gene Expression Profile ofBRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
- (2010) Panagiotis A. Konstantinopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Whole-Genome Profiling of Pediatric Diffuse Intrinsic Pontine Gliomas Highlights Platelet-Derived Growth Factor Receptor α and Poly (ADP-ribose) Polymerase As Potential Therapeutic Targets
- (2010) Maryam Zarghooni et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates
- (2009) Jodi A. Muscal et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- ABT-888 Confers Broad In vivo Activity in Combination with Temozolomide in Diverse Tumors
- (2009) J. P. Palma et al. CLINICAL CANCER RESEARCH
- Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
- (2009) Shivaani Kummar et al. JOURNAL OF CLINICAL ONCOLOGY
- PARP1 expression in pediatric central nervous system tumors
- (2009) Valerie N. Barton et al. PEDIATRIC BLOOD & CANCER
- An enzyme-linked immunosorbent poly(ADP-ribose) polymerase biomarker assay for clinical trials of PARP inhibitors
- (2008) Xuesong Liu et al. ANALYTICAL BIOCHEMISTRY
- A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia
- (2008) Stanley K. Liu et al. RADIOTHERAPY AND ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started